Assessing safety in clinical trials - New podcast out now

Research / 29 June 2023

Medicine safety monitoring applies to all aspects of drug development, but how much is it impacted by patient diversity and study type in clinical trials?

Medicine safety monitoring is important in every stage of drug development, from pre-marketing clinical trials to post-marketing analyses. Yet, certain factors in their design can greatly impact its effectiveness, such as the diversity of the study population, or the complexity of its methodology.

All this and more is discussed in the latest Drug Safety Matters podcast episode, where Marianne Lunzer from AGES and Sanja Prpić from HALMED, review the pros and cons of various study types and the importance of testing medicines on diverse populations, as well as how pre and post-marketing studies are linked to give a more comprehensive picture of patient safety.

Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:

You may also like

Pharmacovigilance, where science meets practice

The theme of this year’s ISoP mid-year symposium encouraged members to reflect on how PV scientists may work better with clinicians to ensure medicine safety for their patients.

Research / 28 June 2023

Digging deeper into Montelukast and nightmares

There is much to be gained from using VigiBase to further explore known adverse reactions to drugs, as some may be having more of an impact on patients than first thought.

Research / 18 September 2023

The colour of signals

Herbal remedies have been used for thousands of years to treat what ails us. Yet why do we still know so little about their potential side effects compared to modern medicines?

Research / 29 August 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more